Loading...
Ion Beam Applications SA
IBAB.BR•EURONEXT
Healthcare
Medical - Devices
€11.68
€-0.46(-3.79%)
Ion Beam Applications SA (IBAB.BR) Financial Performance & Income Statement Overview
Review Ion Beam Applications SA’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
16.21%
↑ 16.21%
Operating Income Growth
239.75%
↑ 239.75%
Net Income Growth
202.09%
↑ 202.09%
Operating Cash Flow Growth
49.42%
↑ 49.42%
Operating Margin
2.87%
↑ 2.87%
Gross Margin
33.32%
↑ 33.32%
Net Profit Margin
1.87%
↑ 1.87%
ROE
9.25%
↑ 9.25%
ROIC
9.72%
↑ 9.72%
Ion Beam Applications SA (IBAB.BR) Income Statement & Financial Overview
Review Ion Beam Applications SA's (IBAB.BR) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $291.75M | $206.45M | $259.30M | $169.42M |
| Cost of Revenue | $195.58M | $136.62M | $169.90M | $124.38M |
| Gross Profit | $96.17M | $69.83M | $89.40M | $45.04M |
| Gross Profit Ratio | $0.33 | $0.34 | $0.34 | $0.27 |
| R&D Expenses | $31.07M | $26.93M | $23.72M | $24.20M |
| SG&A Expenses | $47.84M | $42.87M | $38.97M | $41.13M |
| Operating Expenses | $78.91M | $72.79M | $62.69M | $65.33M |
| Total Costs & Expenses | -$274.49M | $209.41M | $232.59M | $189.71M |
| Interest Income | $0.00 | $0.00 | $0.00 | $4.47M |
| Interest Expense | $0.00 | $4.96M | $0.00 | $6.35M |
| Depreciation & Amortization | $6.04M | $2.59M | $6.10M | $5.42M |
| EBITDA | $24.004M | -$372000.00 | $31.22M | -$10.86M |
| EBITDA Ratio | $0.08 | -$0.002 | $0.13 | -$0.09 |
| Operating Income | $17.26M | -$2.96M | $26.71M | -$20.30M |
| Operating Income Ratio | $0.06 | -$0.01 | $0.10 | -$0.12 |
| Other Income/Expenses (Net) | $1.22M | -$3.86M | -$6.42M | -$2.34M |
| Income Before Tax | $18.47M | -$6.82M | $20.29M | -$22.64M |
| Income Before Tax Ratio | $0.06 | -$0.03 | $0.08 | -$0.13 |
| Income Tax Expense | $2.12M | $3.48M | $4.19M | $4.61M |
| Net Income | $19.60M | -$10.30M | $18.15M | -$27.26M |
| Net Income Ratio | $0.07 | -$0.05 | $0.07 | -$0.16 |
| EPS | $0.65 | -$0.35 | $0.62 | -$0.94 |
| Diluted EPS | $0.65 | -$0.35 | $0.62 | -$0.94 |
| Weighted Avg Shares Outstanding | $30.28M | $29.16M | $29.13M | $29.11M |
| Weighted Avg Shares Outstanding (Diluted) | $30.28M | $29.16M | $29.13M | $29.11M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan